[Held on 3/23] Introducing new functions of the AI program "Cascade Eye" that visualizes and structures the relationships between complex genes and molecules
Based on a huge amount of medical papers (unstructured information), the AI program "Cascade Eye" that can visualize and structure information on molecules and genes related to the disease to be analyzed in the form of a pathway map (route map showing the relationship). Introducing the new features of ".
"Cascade Eye" is an AI program that visualizes the relationships between complex genes and molecules, and is useful for discovering new action mechanisms and indications that are difficult to notice when searching for articles.
Agenda
① FRONTEO's AI solutions in general
② Current status of drug discovery
③Introduction of Cascade Eye
④ Introducing new features of Cascade Eye
◆ Theme: Introduction of new functions of AI program "Cascade Eye" that visualizes and structures the relationships between complex genes and molecules
◆ Date: September 2022, 3 (Wednesday) 23: 17-00: 17
① FRONTEO's AI solutions in general
② Current status of drug discovery
③Introduction of Cascade Eye
④ Introducing new features of Cascade Eye
・ Those who think that the drug discovery process will be streamlined with AI
・ Those involved in drug discovery research
Please refrain from applying for those who use free addresses, those who are in the same industry as our company, or those whose affiliation is unknown.When accessing ZOOM on the day of the event, please enter the name and email address you provided when you applied for the ZOOM participation input field.
Tomoya Ohsumi
After joining IQVIA in 2006, after working in a sales position (MR), he became a project manager, group manager, and new business development manager.He is in charge of marketing, training, consulting and medical related projects with a focus on oncology.He is involved in launching new businesses and organizational reforms such as oncology MRs, MSLs, and clinical educators. From 2019, he will launch a new service for patients as the person in charge of new business development of the patient support program. He received a Master of Business Administration (MBA) from Waseda University Business School in 2020.While in school, he conducted quantitative research on the clinical development of prescription drugs and wrote a master's thesis.
Joined FRONTEO in 2021 and became the head of the medical DX team of the Life Science AI Business Headquarters. Challenge to solve medical problems by utilizing AI.
Articles in the same category
[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI
[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response
[On-site seminar held on 3/19] Latest trends in AI and competition law - from a global perspective <Simultaneous interpretation and reception available>
[Webinar held on 3/5] Are you fully prepared for a series of information leaks?: Recommendation of mock training from a crisis management perspective
[3/13 31st Economic Security Study Session] Strategic importance of “India” towards the post-China era